Strategies for the Management of Spike Protein-Related Pathology
- PMID: 37317282
- PMCID: PMC10222799
- DOI: 10.3390/microorganisms11051308
Strategies for the Management of Spike Protein-Related Pathology
Abstract
In the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least part of their aetiology to the spike protein, which can cause harm through several mechanisms. One significant mechanism of harm is vascular, and it is mediated by the spike protein, a common element of the COVID-19 illness, and it is related to receiving a COVID-19 vaccine. Given the significant number of people experiencing these two related conditions, it is imperative to develop treatment protocols, as well as to consider the diversity of people experiencing long COVID-19 and vaccine injury. This review summarizes the known treatment options for long COVID-19 and vaccine injury, their mechanisms, and their evidentiary basis.
Keywords: COVID-19 vaccine injury; autophagy; inflammation; long COVID; repurposed medication; spike protein; thrombosis.
Conflict of interest statement
M.T.J.H., C.P., and T.A.L. are on the Health and Science Committee of the World Council for Health, a people-centered initiative of the not-for-profit Community Interest Company (CIC) EbMCsquared, for advancing holistic health.
Figures
References
-
- Ritchie H., Mathieu E., Rodés-Guirao L., Appel C., Giattino C., Ortiz-Ospina E., Hasell J., Macdonald B., Beltekian D., Roser M. Coronavirus Pandemic (COVID-19). Our World in Data 2020. [(accessed on 1 October 2022)]. Available online: https://ourworldindata.org/coronavirus.
-
- Staff G. COVID-19 Vaccine Production to January 31st 2022. [(accessed on 1 October 2022)]. Available online: https://globalcommissionforpostpandemicpolicy.org/covid-19-vaccine-produ...
-
- Halma M.T.J., Rose J., Lawrie T. The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review. J. 2023;6:220–235. doi: 10.3390/j6020017. - DOI
-
- ARCHIVE: Conditions of Authorisation for COVID-19 Vaccine Pfizer/BioNTech (Regulation 174) [(accessed on 1 October 2022)]; Available online: https://www.gov.uk/government/publications/regulatory-approval-of-pfizer....
Publication types
LinkOut - more resources
Full Text Sources
